Join the Greater Baltimore Committee and health care professionals at Johns Hopkins and University of Maryland, Baltimore for a discussion on advancements and developments with the COVID-19 vaccines.
- Dr. Anna P. Durbin, Johns Hopkins Bloomberg School of Public Health
- Dr. Lisa Maragakis, Senior Director, Healthcare Epidemiology and Infection Prevention, Johns Hopkins
- Dr. Bruce Jarrell, President, University of Maryland, Baltimore
- Dr. Kathleen Neuzil, Director, Center for Vaccine Development, University of Maryland School of Medicine
Anna P. Durbin, M.D., is a Professor of International Health at the Johns Hopkins Bloomberg School of Public Health (JHSPH) with a joint appointment to the Johns Hopkins University School of Medicine. She is a principal investigator at the Johns Hopkins Bloomberg School of Public Health Center for Immunization Research, which she joined in 1999. She is also affiliated with the Johns Hopkins University Center for Global Health and Johns Hopkins Vaccine Initiative. Dr. Durbin has expertise in the evaluation of a variety of vaccines, including dengue, West Nile and malaria. Dr. Durbin has received the National Institutes of Health (NIH) Merit Award for outstanding basic and translational research, an NIH Director’s Award and the Vaccine Industry Excellence Award for Best Academic Research Team. She earned her medical degree from Wayne State University.
Lisa Maragakis, M.D., M.P.H., is an Associate Professor of medicine and epidemiology at Johns Hopkins University School of Medicine and the Johns Hopkins Bloomberg School of Public Health. Dr. Maragakis is also the Senior Director of Infection Prevention at The Johns Hopkins Health System and the Hospital Epidemiologist for The Johns Hopkins Hospital. Dr. Maragakis also serves as the Executive Director of the Johns Hopkins Hospital Biocontainment Unit and as Incident Commander for the Johns Hopkins Medicine COVID-19 response. She is the Co-Chair of the Centers for Disease Control and Prevention’s Healthcare Infection Control Practices Advisory Committee (HICPAC). She received her medical degree from Johns Hopkins University School of Medicine and a Master in Public Health degree from the Johns Hopkins Bloomberg School of Public Health.
Bruce E. Jarrell, M.D., FACS, was selected as the seventh President of the University of Maryland, Baltimore (UMB) on September 10, 2020, after serving as interim president for eight months. During the interim period, Dr. Jarrell guided the university’s efforts to cope with the COVID-19 pandemic. Dr. Jarrell previously served as Senior Vice President, Executive Vice President and graduate school Dean at UMB. In 2017, as Executive Vice President, Dr. Jarrell oversaw many of the University’s most critical institutional relationships, such as the University of Maryland Strategic Partnership: MPowering the State, UMB’s innovative and structured collaboration with the University of Maryland, College Park. Dr. Jarrell received his medical degree from Jefferson Medical College in Philadelphia.
Kathleen M. Neuzil, M.D., M.P.H., FIDSA, is the Director for the Center for Vaccine Development and Global Health (CVD) and the Myron M. Levine, M.D., DTPH Professor in Vaccinology at the University of Maryland School of Medicine. She is also a Professor in the Departments of Medicine and Pediatrics at the School of Medicine. Dr. Neuzil is one of the world’s most influential research scientists and advocates in the area of vaccine development and policy. At CVD, Dr. Neuzil leads a large Bill & Melinda Gates Foundation-funded consortium to accelerate the introduction of typhoid vaccines into low resource countries and has a robust influenza research program, as well as NIH grants to study influenza and COVID-19. Dr. Neuzil has been instrumental in the national response to COVID-19, and has contributed to more than 230 scientific publications on vaccines and infectious diseases. In December, 2020, she was named as a co-winner by The Baltimore Sun for its Marylander of the Year Award. She earned her medical degree at Johns Hopkins University School of Medicine and a Master in Public Health degree from Vanderbilt University School of Medicine.
When: Tuesday, January 19, 2021; 9 a.m.
Where: Webinar via Zoom
*A personal, one-time link to join the webinar will be sent out via email to all registrants the evening prior to the event.
(If you do not receive your link by 4 p.m. January 15, please contact Lisa Byrd, Director of Events and Business Development, at email@example.com.)
Cost: GBC members: $25, Non-members: $50
For event and sponsorship information, contact Lisa Byrd, Director of Events and Business Development, at firstname.lastname@example.org.
Please submit your questions for the speakers in advance using the event registration form.